IL229151A - פפטיד אנאלוג של 140–t בעלי פעילות סופר–אגוניסטית ונוגדן כנגד 20–cd לטיפול בלימפומה - Google Patents

פפטיד אנאלוג של 140–t בעלי פעילות סופר–אגוניסטית ונוגדן כנגד 20–cd לטיפול בלימפומה

Info

Publication number
IL229151A
IL229151A IL229151A IL22915113A IL229151A IL 229151 A IL229151 A IL 229151A IL 229151 A IL229151 A IL 229151A IL 22915113 A IL22915113 A IL 22915113A IL 229151 A IL229151 A IL 229151A
Authority
IL
Israel
Prior art keywords
cells
benzoyl
peptide
cxcr4
group
Prior art date
Application number
IL229151A
Other languages
English (en)
Other versions
IL229151A0 (he
Inventor
Peled Amnon
Begin Michal
Beider Katia
Abraham Michal
Original Assignee
Peled Amnon
Biokine Therapeutics Ltd
Begin Michal
Beider Katia
Abraham Michal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/IL2007/001597 external-priority patent/WO2008075370A2/en
Application filed by Peled Amnon, Biokine Therapeutics Ltd, Begin Michal, Beider Katia, Abraham Michal filed Critical Peled Amnon
Priority to IL229151A priority Critical patent/IL229151A/he
Publication of IL229151A0 publication Critical patent/IL229151A0/he
Publication of IL229151A publication Critical patent/IL229151A/he

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL229151A 2006-12-21 2013-10-30 פפטיד אנאלוג של 140–t בעלי פעילות סופר–אגוניסטית ונוגדן כנגד 20–cd לטיפול בלימפומה IL229151A (he)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IL229151A IL229151A (he) 2006-12-21 2013-10-30 פפטיד אנאלוג של 140–t בעלי פעילות סופר–אגוניסטית ונוגדן כנגד 20–cd לטיפול בלימפומה

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US87614506P 2006-12-21 2006-12-21
PCT/IL2007/001597 WO2008075370A2 (en) 2006-12-21 2007-12-23 T-140 peptide analogs having cxcr4 super-agonist activity for cancer therapy
IL229151A IL229151A (he) 2006-12-21 2013-10-30 פפטיד אנאלוג של 140–t בעלי פעילות סופר–אגוניסטית ונוגדן כנגד 20–cd לטיפול בלימפומה

Publications (2)

Publication Number Publication Date
IL229151A0 IL229151A0 (he) 2013-12-31
IL229151A true IL229151A (he) 2017-09-28

Family

ID=49784320

Family Applications (1)

Application Number Title Priority Date Filing Date
IL229151A IL229151A (he) 2006-12-21 2013-10-30 פפטיד אנאלוג של 140–t בעלי פעילות סופר–אגוניסטית ונוגדן כנגד 20–cd לטיפול בלימפומה

Country Status (1)

Country Link
IL (1) IL229151A (he)

Also Published As

Publication number Publication date
IL229151A0 (he) 2013-12-31

Similar Documents

Publication Publication Date Title
US8765683B2 (en) T-140 peptide analogs having CXCR4 super-agonist activity for cancer therapy
JP5315372B2 (ja) Ｃｘｃｒ４拮抗薬およびその用途
EP2841084B1 (en) Cxcr4 antagonist peptide for use in the treatment of large cell lung cancer
KR101719339B1 (ko) 혈소판 수준을 증가시키는 펩타이드 요법
US20130303460A1 (en) Peptides and compositions for the treatment of neuroectodermal derived tumors and retinoblastoma
US20080194489A1 (en) Treatment of iatrogenic disease
ES2643321T3 (es) Una combinación de un antagonista de CXCR4 y citarabina para su uso en el tratamiento de la leucemia mieloide
US9034814B2 (en) CXCR4 antagonists for wound healing and re-epithelialization
CA2473890A1 (en) Methods and pharmaceutical compositions for gnrh-i and gnrh-ii modulation of t-cell activity, adhesion, migration and extravasation
KR20180115757A (ko) 급성 골수성 백혈병을 치료하는 방법
IL229151A (he) פפטיד אנאלוג של 140–t בעלי פעילות סופר–אגוניסטית ונוגדן כנגד 20–cd לטיפול בלימפומה
EP1466612A1 (en) Treatment of inflammation and sepsis with hCG derived peptides
WO2022245553A2 (en) Trem-2/dap-12 inhibitors for treating lung disease and injury and combinations thereof
AU2016287787B2 (en) B1SP fusion protein therapeutics, methods, and uses
JP4781621B2 (ja) Ｃｘｃｒ４拮抗薬およびその用途
US20100119476A1 (en) Selection of peptides specific for human blood outgrowth endothelial cells
JP2024521037A (ja) 末梢神経の線維症及び低酸素関連損傷を処置する方法
Skórska Identification and characterization of CD4+ AT2R+ T cell subpopulation in humans and rats
Horii et al. Superior Potential of CD34-Positive Cells Compared to Total Mononuclear Cells for
IALENTI et al. PATHOPHYSIOLOGICAL MECHANISMS AND POSSIBLE THERAPEUTIC TARGETS OF VASCULAR INJURY

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed